期刊文献+

实体瘤中SP细胞亚群的肿瘤相关特性研究进展 被引量:1

Research Progress of Tumor-ralated Characteristic of Side Population Cell in Solid Cancer
原文传递
导出
摘要 SP(Side Population)细胞又叫侧群细胞,是一群能将DNA结合染料Hoechst33342等排出胞外,通过流式细胞仪检测呈Hoechst33342低染的细胞。通过对相关研究分析发现实体肿瘤组织中的SP细胞同样可以通过流式细胞仪分离纯化,由于其具有自我更新、分化等特性被认为其中富集了肿瘤干细胞。目前,在各种实体瘤中都验证了SP细胞的存在,由于具有干细胞及外排内外源化学物质的特性,SP细胞可能是肿瘤复发和耐药的根源,对SP细胞的研究将会给肿瘤的根除提供一套新的策略。 Side population cells is a group of cells with the capacity of efflux DNA fluorescent dye Hoechst 33342 and present a low staining intensity in flow cytometry plot. By analyzing the related research,it's found that SP cells in solid tumor tissues can be separated and purified by flow cytometry. Because of the characteristics of self-renewal and differentiation,it is believed that tumor stem cells are enriched. At present,the existence of SP cells in various solid tumors has been verified,because of the characteristics of stem cells and SP cells,SP cells may be the source of tumor recurrence and drug resistance. And the study of SP cells will be provided to tumor eradication of a new strategy.
出处 《世界科技研究与发展》 CSCD 2015年第5期622-626,共5页 World Sci-Tech R&D
关键词 实体瘤 SP细胞 肿瘤干细胞 耐药 solid tumor side population cell cancer stem cell drug-risistance
  • 相关文献

参考文献51

  • 1GOODELL M A, BROSE K, PARADIS G, et al. Isolation and func- tional properties of mufine hematopoietic stem cells that are replica- ring in vivo [ J ]. Journal of Experimental Medicine, 1996,183 (4) : 1797-1806.
  • 2SUSSMAN R T, RICCI M S, HART L S,et al. Chemotherapy-re- sistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Mye and TRAIL-receptor DR4[ J ]. Cancer 1495. & therapy,2007,6 (9) :1490-.
  • 3RICHARD V, NAIR M G, SANTHOSH KUMAR TR, et al. Side population cells as prototype of chemoresistant, tumor-initiating ceils [J]. BioMed Research International,2013,10(1155) :1-8.
  • 4SIDDIQUI J A, SINGH A, CHAGTOO M,et al. Phytochemicals for Breast Cancer Therapy : Current Status and Future Implications[ J]. Current Cancer Drug Targets ,2014,18 (7) :307-315.
  • 5RISHIL J K, PRANAV G, CHARLES R A J,et al. The modulation of ABC transporter-mediated muhidrug resistance in cancer: A re- view of the past decade[J]. Drug Resistance Updates,2014,10(3) :209-217.
  • 6DECL~VES X, AMIEL A, DELATTRE J Y, et al. Role of ABCTransporters in the Chemoresistance of Human Gliomas [ J ]. Current Cancer Drug Targets,2006,6 (5) :433-455.
  • 7RICHARD V, NAIR M G, SANTHOSH K T R, et al. Side population cells as prototype of chemoresistant, tumor-initiating cells [ J ]. Bi- omed Research Internationan, 2013,12(3) :517-537.
  • 8SHIPITSIN M, POLYAK K et al. The cancer stem cell hypothesis: in search of definitions, markers, and relevance [ J 1. A Journal Of Technical Methods And Pathology ,2008,88 (5) :459-463.
  • 9SKIDAN I, STEINIGER S C. In vivo models for cancer stem cell re- search: a practical guide for frequently used animal models and a- vailable biomarkers [ J ]. Physiol Pharmacol, 2014,65 (2) : 157-69.
  • 10LIU P P, LIAO J, TANG Z Jet al. Metabolic regulation of cancer cell side population by glucose through activation of the Akt path- way [ J]. Cell Death and Diffemetiation,2014,2( 1 ) : 124-135.

同被引文献16

  • 1Regier M, Derlin T, Schwarz D, et al. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) : does the apparent diffusion coefficienl (ADC) correlate with tracer uptake (SUV) ? [ J ]. Eur J Radiol, 2012,81 ( 10 ) : 2913-2918. DOI : 10. l016/j, ejrad. 2011.11. 050.
  • 2Harada H,Seto T, Igawa S, et al. Phase I results of vinorelblne with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI) [ J ]. Int J Radiat Oncol Biol Phys,2012, 82 (5) : 1777-1782. DOI : 10. 1016/j. ijrobp. 2011.03. 037.
  • 3中华医学会呼吸病学分会肺癌学组.中国肺癌防治联盟.原发性支气管肺癌早期诊断中国专家共识(草案)[J].中华结核和呼吸杂志,2014,37(3):0939-1001.
  • 4Heusch P, K~hler J, Wittsack H J, et al. Hybrid [ 1 F ] -FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI) : prelimi- nary results in non-small cell lung cancer (NSCLC) [ J ]. Eur J Radi- ol,2013,82 ( 11 ) : 2055-2060. DOI: 10. 1016/j. ejrad. 2013. 05. 027.
  • 5Gill KK, Kaddoumi A, Nazzal S. Mixed micelles of PEG ( 2000 ) - DSPE and vitamin-E TPGS fbr concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy a- gainst non-sm',dl cell lung cancer( NSCLC ) cell lines [ J ]. Eur J Pharm Sci,2012,46(1/2) :64-71. DOI: 10. 1016/j. ejps. 2012.02. 010.
  • 6李晓舟,杨天月,丁建华.唾液表面增强拉曼光谱用于肺癌的诊断[J].光谱学与光谱分析,2012,32(2):391-393. 被引量:14
  • 7卢永刚,刘凌云,何沙.CD4^+CD25^+调节性T细胞与肿瘤免疫的研究进展[J].中国现代普通外科进展,2013,16(2):134-137. 被引量:9
  • 8宋法云,邢志红.胸腺五肽联合化疗对大肠癌患者细胞免疫功能和生存期的影响研究[J].中国全科医学,2013,16(21):2501-2503. 被引量:9
  • 9林雁,尹芳,袁莹,刘世喜,郑明秀,张京晶.内皮素-1与基质金属蛋白酶-2在喉癌中的表达与浸润转移的相关性研究[J].昆明医科大学学报,2013,34(6):63-66. 被引量:6
  • 10李祥攀,肖建平,陈秀军,张红梅,姜雪松,张烨,徐英杰,李晔雄.肺癌脑转移立体定向放疗后MRI变化及对近期疗效评价影响[J].中华放射肿瘤学杂志,2014,23(1):40-42. 被引量:9

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部